Squarepoint Ops LLC Praxis Precision Medicines, Inc. Transaction History

Squarepoint Ops LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.8 - $4.98 $16,735 - $104,176	20,919 Added 81.66%	46,537 $37,000
Q4 2022 Feb 14, 2023	SELL	$1.88 - $36.45 $284,985 - $5.53 Million	-151,588 Reduced 85.54%	25,618 $60,000
Q3 2022 Nov 14, 2022	BUY	$2.5 - $37.95 $389,115 - $5.91 Million	155,646 Added 721.92%	177,206 $402,000
Q2 2022 Aug 15, 2022	BUY	$1.75 - $11.34 $37,730 - $244,490	21,560 New	21,560 $53,000
Q3 2021 Nov 15, 2021	SELL	$13.15 - $22.56 $229,165 - $393,153	-17,427 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.28 - $33.05 $318,565 - $575,962	17,427 New	17,427 $319,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.